selenocysteine and Glioma

selenocysteine has been researched along with Glioma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cao, MZ; Fan, CD; Fu, XT; Fu, XY; Shao, LR; Sun, BL; Sun, JY; Yang, MF; Yang, XY; Zhang, HF; Zhang, ZY; Zhao, SJ1
Fan, CD; Fu, XT; Fu, XY; Hou, YJ; Li, Y; Sun, BL; Sun, JY; Wang, K; Yang, MF; Yi, SY; Zhai, J1

Other Studies

2 other study(ies) available for selenocysteine and Glioma

ArticleYear
Selenocysteine induces apoptosis in human glioma cells: evidence for TrxR1-targeted inhibition and signaling crosstalk.
    Scientific reports, 2017, 07-25, Volume: 7, Issue:1

    Topics: Animals; Antineoplastic Agents; Apoptosis; Brain Neoplasms; Cell Line, Tumor; DNA Damage; Glioma; Humans; MAP Kinase Signaling System; Mice, Inbred BALB C; Mitochondria; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Selenocysteine; Signal Transduction; Thioredoxin Reductase 1; Xenograft Model Antitumor Assays

2017
Induction of S-Phase Arrest in Human Glioma Cells by Selenocysteine, a Natural Selenium-Containing Agent Via Triggering Reactive Oxygen Species-Mediated DNA Damage and Modulating MAPKs and AKT Pathways.
    Neurochemical research, 2016, Volume: 41, Issue:6

    Topics: Antineoplastic Agents; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Survival; DNA Damage; Glioma; Humans; MAP Kinase Signaling System; Oncogene Protein v-akt; Reactive Oxygen Species; Selenium; Selenocysteine

2016